QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

By Anita Dushyanth, PhD NASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer's disease

 fda-issues-warning-letter-to-allergan-for-failing-to-comply-with-requirements--under-2-separate-premarket-approval-orders

-Reuters

 the-daily-biotech-pulse-fda-approves-novartis-lung-cancer-drug-2-way-contest-emerging-for-tetraphase-pharma-dexcom-to-join-sp-500

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitti...

 the-daily-biotech-pulse-fda-nod-for-astrazeneca-abbvie-allergan-deal-clears-antitrust-hurdle

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hittin...

Core News & Articles

-Reuters

Core News & Articles

Upgrades

 suntrust-robinson-humphrey-downgrades-allergan-to-hold-raises-price-target-to-193

SunTrust Robinson Humphrey analyst Gregg Gilbert downgrades Allergan (NYSE:AGN) from Buy to Hold and raises the price target...

 abbvie-analyst-upgrades-stock-to-outperform-looks-forward-to-2021

AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at...

 cfra-downgrades-allergan-to-hold
CFRA Downgrades Allergan to Hold
03/25/2020 16:43:53

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION